Below, we review what is currently known about bpc 157, including possible benefits, before-and-after observations, administration routes, safety considerations, and what to keep in mind when discussing BPC-157 with a qualified healthcare professional
FIGURE 1 The Hgf/c-Met Axis Hepatocyte growth factor was originally discovered in in vitro experiments as a hepatocyte mitogen (Nakamura et al., 1984) for primary hepatocytes that promoted the cell motility of epithelial cells (Stoker et al., 1987)
The longevity medicine community has begun integrating BPC-157 into broader protocols that address the biological underpinnings of aging: chronic low-grade inflammation, impaired tissue repair capacity, gut barrier dysfunction, and declining growth factor signaling
These effects occur through mechanisms including enhanced angiogenesis, modulation of growth factor expression, and direct cytoprotection of gastric epithelial cells
Reaching these doses requires eight to sixteen weeks of gradual escalation for each component, with coordination to avoid escalating both simultaneously